Atlas Trials

Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma

Clinical trial NCT01175980 · COMPLETED

Trial details

NCT number
NCT01175980
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Oral Cavity Adenoid Cystic CarcinomaRecurrent Salivary Gland CarcinomaSalivary Gland Adenoid Cystic CarcinomaStage III Major Salivary Gland Cancer AJCC v7Stage III Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7Stage IVA Major Salivary Gland Cancer AJCC v7Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7Stage IVB Major Salivary Gland Cancer AJCC v7Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7Stage IVC Major Salivary Gland Cancer AJCC v7Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7Tongue Carcinoma
Start date
2010-08-06
Primary completion
2018-06-08
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.